Kashfia Chowdhury

机构：MRC Clinical Trials Unit at UCL, Comprehensive Clinical Trials, University College London · ORCID：0000-0002-8185-5152

发表论文 53 篇 · 总被引 2273 次 · h-index 17

代表论文

• Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial (2025 · The Lancet · 被引 149)
• Total Ankle Replacement Versus Arthrodesis for End-Stage Ankle Osteoarthritis (2022 · Annals of Internal Medicine · 被引 90)
• Clinical effectiveness of the psychological therapy Mental Health Intervention for Children with Epilepsy in addition to usual care compared with assessment-enhanced usual care alone: a multicentre, randomised controlled clinical trial in the UK (2024 · The Lancet · 被引 41)
• Total ankle replacement versus ankle arthrodesis for patients aged 50–85 years with end-stage ankle osteoarthritis: the TARVA RCT (2023 · Health Technology Assessment · 被引 34)
• Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 (2022 · PLoS Medicine · 被引 34)
• Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study (2025 · Inflammatory Bowel Diseases · 被引 12)